|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 405/12 | (2006.01) |
| A61K 31/5377 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) |
| (11) | Number of the document | 3184523 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16191716.6 |
| Date of filing the European patent application | 2013-04-11 | |
| (97) | Date of publication of the European application | 2017-06-28 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-19 |
| (46) | Date of publication of the claims translation | 2020-02-10 |
| (30) | Number | Date | Country code |
| 201261624215 P | 2012-04-13 | US |
| (72) |
KUNTZ, Kevin Wayne, US
HUANG, Kuan-chun, US
CHOI, Hyeong Wook, US
SANDERS, Kristen, US
MATHIEU, Steven, US
CHANDA, Arani, US
FANG, Frank, US
|
| (73) |
Epizyme Inc,
400 Technology Square, 4th Floor, Cambridge, MA 02139,
US
Eisai R&D Management Co., Ltd., 6-10, Koishikawa-4-chome Bunkyo-ku, Tokyo 112-8088, JP |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | N-((4,6-dimetil-2-okso-1,2-dihidropiridin-3-il)metil)-5-(etil (tetrahidro-2H-piran-4-il)amino)-4-metil-4'-(morfolinometil)-[1,1'-bifenil]-3-karboksamido hidrobromidas, skirtas naudoti hematologinės sistemos proliferacinio sutrikimo gydymui |
| N-((4,6-DIMETHYL-2-OXO-L,2-DIHYDROPYRIDIN-3-YL)METHYL)-5-(ETHYL (TETRAHYDRO-2H-PYRAN-4-YL)AMINO)-4-METHYL-4`-(MORPHOLINOMETHYL)-[L,1`-BIPHENYL]-3-CARBOXAMIDE HYDROBROMIDE FOR USE IN THE TREATMENT OF ACELL PROLIFERATIVE DISORDER OF THE HEMATOLOGIC SYSTE |
| Payment date | Validity (years) | Amount | |
| 2025-03-05 | 13 | 289.00 EUR |
| 2026-04-11 |